BUGS BIOSCIENCE LIMITED
Company number 08911333 · Active · London NW1 0NH
BUGS BIOSCIENCE LIMITED is an active private limited company (company number 08911333) incorporated on 25 February 2014, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 28 February 2026, showing net assets of £15k and cash of £16k, with 0 employees on average. Net assets fell 52% on the prior period (£32k).
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 25 February 2014
- Next accounts due
- 28 November 2027 — in 406 days
- Confirmation statement due
- 11 March 2027 — in 144 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 28 February 2026
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2026 | £15k | £16k | £82 | — | — | — | 0 |
| 28 February 2025 | £32k | £31k | £1,386 | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 60/100 (grade C)
- +10 Positive net assets — Net assets £15,217 at 2026-02-28
- -8 Net assets falling — -51.9% vs prior period
- +8 Established — Incorporated 2014-02-25 (13 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Graham Robert Snudden — owns 25–50% of shares · since 6 April 2016
- Dr Jason Hinds — owns 25–50% of shares · since 25 July 2023
- St George's Hospital Medical School (corporate entity, United Kingdom) — owns 25–50% of shares · since 25 July 2023
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- OXSYBIO LIMITED — London, inc. Mar 2014
- SIME DIAGNOSTICS LIMITED — London, inc. Feb 2014
- TPPN LTD — London, inc. Apr 2014
- REBIO TECHNOLOGIES LIMITED — London, inc. Jan 2014
- CHAIN BIOTECHNOLOGY LIMITED — London, inc. Jan 2014
- PHOENIX DX LTD — London, inc. Jan 2014
Reminders for BUGS BIOSCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.